{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T19:31:58Z","timestamp":1696534318272},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T00:00:00Z","timestamp":1421020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Since the introduction of combined antiretroviral therapy, human immunodeficiency virus (<jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>) infection is no longer a contraindication for solid organ transplantation. In <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/hepatitis C virus (<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>)\u2010coinfected patients undergoing liver transplantation, <jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010related cirrhosis, drug\u2010drug interactions, and calcineurin inhibitors\u2010related toxicity affect clinical outcomes. Therapeutic drug monitoring can be useful to assess antiretroviral over\u2010 or underexposure in this cohort. We report the clinical characteristics along with antiretroviral trough levels of maraviroc, darunavir, and etravirine in 3 <jats:styled-content style=\"fixed-case\">HIV<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">HCV<\/jats:styled-content>\u2010coinfected liver transplant recipients who developed post\u2010transplant liver cirrhosis.<\/jats:p>","DOI":"10.1111\/tid.12339","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T13:57:22Z","timestamp":1421071042000},"page":"147-153","source":"Crossref","is-referenced-by-count":4,"title":["Antiretroviral blood levels in <scp>HIV<\/scp>\/<scp>HCV<\/scp>\u2010coinfected patients with cirrhosis after liver transplant: a report of three cases"],"prefix":"10.1111","volume":"17","author":[{"given":"E.","family":"Righi","sequence":"first","affiliation":[{"name":"Infectious Diseases Department Santa Maria della Misericordia University Hospital Udine Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Londero","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Santa Maria della Misericordia University Hospital Udine Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Pea","sequence":"additional","affiliation":[{"name":"Clinical Pharmacology Department Santa Maria della Misericordia University Hospital Udine Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bonora","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Amedeo di Savoia Hospital Turin Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Nasta","sequence":"additional","affiliation":[{"name":"University Division of Infectious and Tropical Diseases University of Brescia and Spedali Civili General Hospital Brescia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Della Siega","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Santa Maria della Misericordia University Hospital Udine Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Delle Foglie","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Trento Hospital Trento Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Villa","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Santa Maria della Misericordia University Hospital Udine Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Giglio","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Sant'Anna Hospital Como Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Dal Zoppo","sequence":"additional","affiliation":[{"name":"University Division of Infectious and Tropical Diseases University of Brescia and Spedali Civili General Hospital Brescia Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Baccarani","sequence":"additional","affiliation":[{"name":"Liver Transplant Unit Santa Maria della Misericordia University Hospital Udine Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bassetti","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Santa Maria della Misericordia University Hospital Udine Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,1,12]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"63","article-title":"Review of transplantation in HIV patients during the HAART era","author":"Pelletier SJ","year":"2004","journal-title":"Clin Transpl"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001197"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2011.03906.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.23411"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.01.022"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i18.5353"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22431"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21990"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02061.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2012.0169"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.1860"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04800908"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21900"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200847030-00002"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00370705"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1086\/426021"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1086\/512086"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOT.0b013e3283592684"},{"key":"e_1_2_6_20_1","volume-title":"Guidelines for the Use of Antiretroviral Agents in HIV\u20101\u2010Infected Adults and Adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2011"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23315"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e318189596d"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2014.01.031"},{"key":"e_1_2_6_24_1","unstructured":"Food and Drug Administration (FDA).Prezista (package insert) 2010. Available athttp:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2010\/021976s016lbl.pdf."},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31802b4956"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.181"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200746110-00002"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200202150-00032"},{"key":"e_1_2_6_29_1","unstructured":"TommasiC NicastriE GalloAL et\u00a0al.Raltegravir and darunavir plasma pharmacokinetic in HIV\u20101 infected patients with advanced liver disease. 11th International Workshop on Clinical Pharmacology and HIV Therapy. April 7\u20139 2010.Sorrento Italy. Abstract 10."},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt386"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr498"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2009.02684.x"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1086\/596503"},{"key":"e_1_2_6_34_1","unstructured":"BarauC BraunJ VincentC et\u00a0al.Pharmacokinetic study of raltegravir in HIV\u2010infected patients with end stage liver disease: LIVERAL ANRS 148 study. Poster 167 20th Conference on Retroviruses and Opportunistic Infections (CROI) March 3\u20136 2013 Atlanta GA."},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks486"},{"key":"e_1_2_6_36_1","volume-title":"Selzentry [Prescribing Information]","author":"Pfizer, Inc","year":"2010"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/PHAR.1003"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12339","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T18:19:37Z","timestamp":1695493177000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/tid.12339"],"URL":"https:\/\/doi.org\/10.1111\/tid.12339","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,12]]}}}